Compound (ϩ)-3-((␣-R)-␣-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide , is one of a series of novel centrally acting agents with potent antinociceptive activity that binds specifically and with high affinity to opioid receptors. In saturation equilibrium binding studies performed at 25°C using membranes from rat brain or guinea pig cerebellum, the K i values measured for DPI-3290 at ␦-, -, and -opioid receptors were 0.18 Ϯ 0.02, 0.46 Ϯ 0.05, and 0.62 Ϯ 0.09 nM, respectively. In vas deferens isolated from laboratory mice, DPI-3290 decreased electrically induced tension development in a concentration-dependent manner with corresponding IC 50 values of 1.0 Ϯ 0.3, 6.2 Ϯ 2.0, and 25.0 Ϯ 3.3 nM at ␦-, -, and -receptors, respectively. The activity of DPI-3290 in isolated vas deferens tissue was approximately 20,000, 175.8, and 1500 times more efficacious than morphine, and 492, 2.5, and 35 times more efficacious than fentanyl at ␦-, -, and -receptors, respectively. In ileal strips isolated from guinea pigs, DPI-3290 inhibited tension development with a corresponding IC 50 value of 3.4 Ϯ 1.6 nM at -opioid receptors and 6.7 Ϯ 1.6 nM at -opioid receptors. Intravenous administration of 0.05 Ϯ 0.007 mg/kg DPI-3290 produced a 50% antinociceptive response in rats. The antinociceptive properties of DPI-3290 were blocked by naloxone (0.5 mg/kg s.c.). Compared with morphine, this study demonstrated that DPI-3290 is more potent and elicited a similar magnitude of antinociceptive activity in the rat, actions mediated by its mixed opioid receptor agonist activity. The marked antinociceptive activity of DPI-3290 will likely provide a means for relieving severe pain in patients that require analgesic treatment.Nucleotide sequences for three distinct pertussis toxinsensitive heterotrimeric GTP binding protein-coupled opioid receptors have been reported with approximately 65% homology existing between their amino acids (Kieffer et al., 1992; Chen et al., 1993a,b). These distinct opioid receptors termed , ␦, and are the binding sites for the endogenous peptide molecules endorphins, enkephalins, and dynorphins that have been shown to elicit a variety of pharmacological actions (Chang, 1984). The most notable of these opioid receptormediated actions is analgesia.Opioids produce their therapeutic effects by acting at the same receptors as the endogenous opioid peptides (Erspamer et al., 1989). They alter synaptic transmission by modulating the presynaptic release of neurotransmitters such as acetylcholine, norepinephrine, serotonin, dopamine, and substance P (Hagelberg et al., 2002). Changes in receptor-operated potassium currents, adenylate cyclase activity and intracellular free ionized calcium concentrations all have been reported to contribute to these changes in synaptic transmission (Fan and Crain, 1995;Murthy and Makhlouf, 1996). To date, hyperpolarization of membrane potential and the corresponding effects on voltage-sensitive calcium channels (Tang et al., 1994) togeth...